RT Journal Article
SR Electronic
T1 Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.30.24314638
DO 10.1101/2024.09.30.24314638
A1 Rø, Gunnar
A1 Lyngstad, Trude Marie
A1 Seppälä, Elina
A1 Skodvin, Siri Nærland
A1 Trogstad, Lill
A1 White, Richard Aubrey
A1 Paulsen, Arve
A1 Paulsen, Trine Hessevik
A1 Ofitserova, Trine Skogset
A1 Langlete, Petter
A1 Madslien, Elisabeth Henie
A1 Nygård, Karin
A1 Freisleben de Blasio, Birgitte
YR 2024
UL http://medrxiv.org/content/early/2024/10/01/2024.09.30.24314638.abstract
AB Background Estimating the trend of new infections was crucial for monitoring risk and for evaluating strategies and interventions during the COVID-19 pandemic. The pandemic revealed the utility of new data sources and highlighted challenges in interpreting surveillance indicators when changes in disease severity, testing practices or reporting occur.Aim To estimate the trend in new COVID-19 infections by combining estimates of growth rates from all available surveillance indicators in Norway.Methods We estimated growth rates from ten different surveillance indicators in Norway by using a negative binomial regression method and aligned the growth rates in time to hospital admissions by maximising correlations. Using a meta-analysis framework, we calculated overall growth rates and reproduction numbers including assessments of the heterogeneity between indicators.Results The estimated growth rates reached a maximum of 25% per day in March 2020, but afterwards they were between -10% and 10% per day. The correlations between the growth rates estimated from different indicators were between 0.5 and 1.0. Growth rates from indicators based on wastewater, panel and cohort data can give up to 14 days earlier signals of trends compared to hospital admissions, while indicators based on positive lab tests can give signals up to 7 days earlier.Conclusions Combining estimates of growth rates from multiple surveillance indicators provides a good description of the COVID-19 pandemic in Norway. This is a powerful technique for a holistic understanding of the trends of new COVID-19 infections and the technique can easily be adapted to new data sources and situations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:https://github.com/folkehelseinstituttet/covid19_trendI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data is available online at: https://github.com/folkehelseinstituttet/covid19_trend